A real-world disproportionality analysis of ripretinib data mining of the public version of FDA adverse event reporting system.

Front Pharmacol · 2025 · PMC11959022 · PMID 40170718

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Thereafter, there was a decreasing trend in AEs over time, over the next 6 months.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.